Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Sep 26, 2022; 10(27): 9602-9610
Published online Sep 26, 2022. doi: 10.12998/wjcc.v10.i27.9602
COVID-19 and the cardiovascular system-current knowledge and future perspectives
Dimitrios G Chatzis, Kalliopi Magounaki, Ioannis Pantazopoulos, Sonu Menachem Maimonides Bhaskar
Dimitrios G Chatzis, Medical School, European University Cyprus, Nicosia 2404, Cyprus
Kalliopi Magounaki, Department of Internal Medicine, KAT General Hospital, Athens 14561, Greece
Ioannis Pantazopoulos, Department of Emergency Medicine, Faculty of Medicine, University of Thessaly, Larissa 41500, Greece
Sonu Menachem Maimonides Bhaskar, NSW Brain Clot Bank, NSW Health Pathology, Sydney, NSW 2170, Australia
Sonu Menachem Maimonides Bhaskar, Department of Neurology and Neurophysiology, Liverpool Hospital and South Western Sydney Local Health District, Sydney, NSW 2170, Australia
Author contributions: Chatzis DG, Magounaki K, Pantazopoulos I, and Bhaskar SMM wrote the manuscript. All authors have equally contributed in the preparation of this manuscript.
Conflict-of-interest statement: All authors report no conflict of interest.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See:
Corresponding author: Dimitrios G Chatzis, MD, PhD, Chief Doctor, Consultant Physician-Scientist, Lecturer, Medical School, European University Cyprus, 6 Diogenis Street, Nicosia 2404, Cyprus.
Received: May 15, 2022
Peer-review started: May 15, 2022
First decision: June 8, 2022
Revised: June 29, 2022
Accepted: August 16, 2022
Article in press: August 16, 2022
Published online: September 26, 2022
Core Tip

Core Tip: It is well established that severe acute respiratory syndrome coronavirus-2 has a high propensity to attack cardiovascular system with various clinical manifestations namely myocarditis and myocardial injury, cardiac arrest, acute coronary syndromes, hypercoagulability and venous thromboembolism, as well as heart failure. Currently, there is no established, specific therapy for the treatment of coronavirus disease-induced cardiovascular involvement and there is ongoing research on this topic.